Merck - Enterprise Tech Ecosystem Series

Merck - Enterprise Tech Ecosystem Series

Merck handles a lot of regulatory documentation work in order to ensure that all its business divisions comply with government and industry policies. It has been strengthening its digital expertise by implementing digital processes to improve the employee experience and optimize internal workflow procedures.

Having several siloed database systems supporting various functions like research, supply chain, and manufacturing has been a major issue for Merck over the years. These silos restricted how the company could use them to support its overall goals and kept data segregated. To address this issue, Merck deployed the Appian platform, an-end-to-end solution for cohesively connecting data and unstructured information.

Merck has integrated a forward looking and dedicated digital health strategy into its overall enterprise priorities, whether using big data and analytics for efficient drug development process, tapping advanced technologies to improve its services, or collaborating or investing in technology companies.

The report provides information and insights into Mercks technology activities, including -
- Insights of its digital transformation strategies, accelerator programs, and innovation/technology centers
- Overview of technology initiatives covering strategic partnerships and product launches
- Overview of technology focused investments and acquisitions
- Insights on each technology initiative including technology theme, objective, and benefits
- Details of estimated ICT budgets and major ICT contracts


- Merck is exploring and utilizing technologies including 3D printing, AI & machine learning, big data, blockchain, cybersecurity, EMR/EHR systems, cloud, IoT, mobile health, robotics, virtual & augmented reality, wearable tech, and genomics.
- Merck has been tapping the power of big data to improve its clinical trials and drug development/manufacturing process.
- The company has established a Global Health Innovation Fund (GHI) to back digital health companies through funding and direct investments.

Reasons to Buy

- Gain insights into Mercks technology operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches, partnerships, investments, and acquisitions of Merck.

Digital Transformation Strategy
Accelerator Programs and Innovation/Technology Centers
Technology Focus
Technology Initiatives
Venture Arm - Merck Global Health Innovation (GHI)
Merck Global Health Innovation (GHI) Investments
Merck Investments
Partnership, Investment, & Acquisition Network Map
ICT Budgets & Contracts
Key Executives
About GlobalData

Merck & Co., Inc. - Enterprise Tech Ecosystem Series

Merck & Co., Inc. - Enterprise Tech Ecosystem SeriesMerck & Co Inc. (Merck) is a multinational healthcare company that is engaged in the discovery, development, manufacture, and commercialization of prescription

USD 1495 View Report

Enterprise Tech Ecosystem Series - Merck & Co Inc.

Enterprise Tech Ecosystem Series - Merck & Co Inc. market research report available in single user pdf license with Aarkstore Enterprise at USD 1295

USD 1295 View Report

Cognizant Technology Solutions Corp. - Enterprise Tech Ecosystem Series

Cognizant Technology Solutions Corp. - Enterprise Tech Ecosystem SeriesCognizant Technology Solutions Corp (CTS) is a provider of information technology (IT), consulting and business process outsourcing (BPO) services. The company offerings

USD 1495 View Report

Raytheon Technologies - Enterprise Tech Ecosystem Series

Raytheon Technologies - Enterprise Tech Ecosystem SeriesRaytheon Technologies Corp (RTX), formerly United Technologies Corp, is a provider of technology products and services to the aerospace and defense industries. The companys

USD 1495 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available